Skip to main content
. 2012 Oct 3;14(5):e126. doi: 10.2196/jmir.2216

Table 1.

Judgments of methodological quality in the reviewed randomized controlled trials of electronic symptom reportinga.

Article Theoretical evidence/
preclinical testing
Random
sequence
generationb
Allocation
concealmentb
Blinding of
participants
and personnelb,c
Blinding of
outcome
assessmentb,d
Incomplete
outcome datab
Selective
reportingb,d
Berger et al [59] yes/yes + + – – + +
Bergström et al [60] yes/unclear + + – + + +
Berry et al [34] yes/yes + + – – + –
Boyes et al [35] yes/no ○ ○ – – – –
Carrasco et al [52] yes/no + – – – + +
Chan et al [42] yes/no + ○ – – ○ –
Chan et al [43] yes/yes + ○ – – – –
DeVito Dabbs et al [55] yes/yes + – – – + +
Glasgow et al [63] yes/yes + + – – ○ +
Guendelman et al [44] yes/yes ○ + – – + +
Jan et al [45] yes/no ○ + – – + –
Kearney et al [41] yes/yes + + – – – –
Leveille et al [40] yes/no ○ ○ – – + +
Lewis et al [49] (hospitalization) yes/unclear + + – + ○ –
Lewis et al [50] (quality of life) unclear/unclear + + – – ○ –
Nguyen et al [58] yes/yes + + – – – +
Nguyen et al [51] yes/no + + – – + –
Oerlemans et al [62] yes/no + – – – + +
Prabhakaran et al [46] no/no + + – – + –
Rasmussen et al [47] yes/no – + – – ○ +
Ruland et al [36] yes/yes ○ ○ – ○ ○ +
Ruland et al [37] yes/yes + – – + + +
Santamore et al [53] no/no ○ ○ – – ○ –
Schwarz et al [54] yes/no + + – + + +
Stevens et al [39] yes/no + ○ – – – –
van der Meer et al [57] yes/unclear + + – – + +
Velikova et al [38] yes/no + ○ – + + +
Vernmark et al [61] yes/no + ○ – + + +
Wagner et al [65] yes/no + ○ – – + +
Willems et al [48] yes/no + – – – + +
Williams et al [64] no/no ○ ○ – – ○ ○
Yardley et al 2010 [56] yes/no + + + + – ○

a Articles were identified in a comprehensive search in Medline, EMBASE, PsycINFO, Cochrane Central Register of Controlled Trials, and IEEE Xplore from 1990 to November 2011, and were published in the time period 2002–2011.

b + = low risk, ○ = unclear risk, and – = high risk.

c Blinding of participants and personnel is extremely challenging in telemedicine and eHealth innovations. We thus did not consider this bias to be crucial to the quality judgment of the articles.

d We considered a low risk of bias for selective reporting and for blinding of outcome assessment to be the best indicators for identification of studies with high methodological quality.